Recruiting NA INTERVENTIONAL 2-arm NCT03742687

Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC

HERAN-Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC

Sponsor: Aarhus University Hospital

Conditions Radiotherapy Side Effect Stage III Non-small-cell Lung Cancer Stage IV Non-small Cell Lung Cancer

Interventions Heterogeneously Hypofractionated Radiotherapy

Updated 7 times since 2018 Last updated: Sep 8, 2023 Started: Nov 22, 2018 Primary completion: Dec 30, 2023 Completion: Dec 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Radiotherapy Side Effect and Stage III Non-small-cell Lung Cancer, this trial is actively recruiting participants. The trial is conducted by Aarhus University Hospital and has accumulated 7 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Oct 2023 — Jul 2024 [monthly]

Recruiting NA
Sep 2022 — Oct 2023 [monthly]

Recruiting NA
Jan 2021 — Sep 2022 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Mar 2019 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Dec 2018 — Mar 2019 [monthly]

Not Yet Recruiting NA

First recorded

Nov 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aarhus University Hospital
Danish Lung Cancer Group
Herlev Hospital
Odense University Hospital
Rigshospitalet, Denmark
Vejle Hospital

Data source: Danish Lung Cancer Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aarhus, Denmark